Rhode Island Blood Center, A Division of New York Blood Center, Inc.

Form 483

Providence, Rhode Island, United StatesFEI 1270007Issued November 07, 2016

View FDA's Record for This Firm

Source: FDA inspection record. Confirmed against FDA's published inspection data for this establishment and inspection date. FDA has published the inspection and what it cited, but not the form itself, which usually takes six to twelve months. To check it, open FDA's record for this establishment on FDA's Data Dashboard, listed under FEI 1270007.

Observations1

Issue DateNovember 07, 2016

StatusNo Warning Letter

Related Inspections8

Establishment Details

Firm: Rhode Island Blood Center, A Division of New York Blood Center, Inc.
Location: Providence, Rhode Island, United States
FEI Number: 1270007
Product Type: Biologics
Issue Date: November 07, 2016
Country: United States

Inspection History, 2011 to 2025

NAI3

VAI5

NAI means No Action Indicated. VAI means Voluntary Action Indicated.

Act on This Form 483

FDA Inspection ReadinessSee how your operations would hold up to the same scrutiny.CAPA & InvestigationsScore how you would investigate and close findings like these.Talk to a SpecialistWalk through these observations with a ComplianceQuest expert.

Rhode Island Blood Center, A Division of New York Blood Center, Inc. FDA Form 483, Providence, Rhode Island, November 7, 2016